Description

Priorix Lyophilisate for Solution for Injections №1 Vial

Ingredients:

Each vial contains:

• Measles virus strain Schwarz ≥ 10^3.0 CCID50
• Mumps virus strain RIT4385 ≥ 10^3.7 CCID50
• Rubella virus strain Wistar RA 27/3 ≥ 10^3.0 CCID50

Dosage:

Recommended dosage: One vial administered via subcutaneous injection.
Dosage regimen: A single dose is usually sufficient for immunization.

Indications:

Priorix is indicated for active immunization against measles, mumps, and rubella in individuals aged 12 months and older.

Contraindications:

Do not administer Priorix in individuals with:

• History of severe allergic reaction to any component of the vaccine
• Immunodeficiency
• Pregnancy

Directions:

Priorix should be administered by healthcare professionals trained in immunization techniques.

• Ensure proper storage and handling of the vaccine.
• Reconstitute the lyophilisate with the provided diluent before administration.
• Administer the vaccine via subcutaneous injection.

Scientific Evidence:

Priorix has demonstrated high efficacy in preventing measles, mumps, and rubella. Clinical trials have shown that a single dose of Priorix can induce strong and long-lasting immunity against these viral diseases. Studies have also highlighted the safety profile of the vaccine, with mild and transient side effects being the most commonly reported.

The pharmacological action of Priorix involves stimulating the immune system to produce protective antibodies against the measles, mumps, and rubella viruses. By mimicking natural infections without causing the diseases, the vaccine primes the body’s defenses to recognize and combat these viruses upon future exposure.